Croatia vs Guinea-Bissau: Pneumococcal conjugate second or third-dose vaccines (PCVc)
Croatia
89.0%
in 2025
Guinea-Bissau
90.0%
in 2025
Croatia rank
72nd
Guinea-Bissau rank
70th
Pneumococcal conjugate second or third-dose vaccines (PCVc) over time
- Croatia
- Guinea-Bissau
How they compare
Guinea-Bissau currently reports 90.0% against 89.0% in Croatia, a difference of 1.0%.
The two have swapped places 2 times across 18 shared years of data; in 2008 it was Guinea-Bissau ahead.
Croatia ranks 72nd and Guinea-Bissau ranks 70th of 194 countries.
Guinea-Bissau has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Croatia | Guinea-Bissau | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 0.0% | 0.0% | 0.0% | — |
| 2010s | 0.0% | 34.1% | 34.1% | Guinea-Bissau |
| 2020s | 72.2% | 85.5% | 13.3% | Guinea-Bissau |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher pneumococcal conjugate second or third-dose vaccines (pcvc), Croatia or Guinea-Bissau?
- Guinea-Bissau, at 90.0% against 89.0% in Croatia as of 2025.
- What is the difference in pneumococcal conjugate second or third-dose vaccines (pcvc) between Croatia and Guinea-Bissau?
- 1.0%, with Guinea-Bissau ahead.
- How many years of comparable data are there for Croatia and Guinea-Bissau?
- 18 years are reported by both, from 2008 to 2025.
- How do Croatia and Guinea-Bissau rank globally for pneumococcal conjugate second or third-dose vaccines (pcvc)?
- Croatia ranks 72nd and Guinea-Bissau ranks 70th of 194 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Pneumococcal conjugate second or third-dose vaccines (PCVc) immunization coverage by the locally recommended age (%) (WUENIC). Statizoid refreshes it automatically from the source and publishes the full history for both places.